Detalhe da pesquisa
1.
Molecular mechanisms of environmental exposures and human disease.
Nat Rev Genet
; 24(5): 332-344, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36717624
2.
Extracellular Vesicle-Encapsulated microRNAs as Novel Biomarkers of Lung Health.
Am J Respir Crit Care Med
; 207(1): 50-59, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35943330
3.
Lung function impairment and risk of incident heart failure: the NHLBI Pooled Cohorts Study.
Eur Heart J
; 43(23): 2196-2208, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35467708
4.
Multivariable regression: understanding one of medicine's most fundamental statistical tools.
Knee Surg Sports Traumatol Arthrosc
; 31(1): 7-11, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36323796
5.
Unsupervised machine learning methods and emerging applications in healthcare.
Knee Surg Sports Traumatol Arthrosc
; 31(2): 376-381, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36378293
6.
Fragility Part I: a guide to understanding statistical power.
Knee Surg Sports Traumatol Arthrosc
; 30(12): 3924-3928, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36205762
7.
Environmental Exposures and Extracellular Vesicles: Indicators of Systemic Effects and Human Disease.
Curr Environ Health Rep
; 9(3): 465-476, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35449498
8.
Predicting risk of lung function impairment and all-cause mortality using a DNA methylation-based classifier of tobacco smoke exposure.
Respir Med
; 200: 106896, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35716602
9.
Early Mobilization during Extracorporeal Membrane Oxygenation for Cardiopulmonary Failure in Adults: Factors Associated with Intensity of Treatment.
Ann Am Thorac Soc
; 19(1): 90-98, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077700
10.
Environmental Exposures and Lung Aging: Molecular Mechanisms and Implications for Improving Respiratory Health.
Curr Environ Health Rep
; 8(4): 281-293, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34735706
11.
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19.
J Clin Invest
; 131(13)2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33974559
12.
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Trials
; 21(1): 927, 2020 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203476
13.
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Trials
; 21(1): 499, 2020 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513308
14.
Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Trials
; 21(1): 536, 2020 06 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32546220
15.
CD24Fc: an emerging COVID-19 therapy.
Lancet Infect Dis
; 22(5): 565-567, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35286842